YAP–VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP

Abstract

The Hippo–YAP signaling pathway plays a critical role in development, homeostasis, regeneration, and tumorigenesis by converging on YAP, a coactivator for the TEAD family DNA-binding transcription factors, to regulate downstream transcription programs. Given its pivotal role as the nuclear effector of the Hippo pathway, YAP is indispensable in multiple developmental and tissue contexts. Here we report that the essentiality of YAP in liver and lung development can be genetically bypassed by simultaneous inactivation of the TEAD corepressor VGLL4. This striking antagonistic epistasis suggests that the major physiological function of YAP is to antagonize VGLL4. We further show that the YAP–VGLL4 antagonism plays a widespread role in regulating Hippo pathway output beyond normal development, as inactivation ofVgll4dramatically enhanced intrahepatic cholangiocarcinoma formation inNf2-deficient livers and ameliorated CCl4-induced damage in normal livers. Interestingly,Vgll4expression is temporally regulated in development and regeneration and, in certain contexts, provides a better indication of overall Hippo pathway output than YAP phosphorylation. Together, these findings highlight the central importance of VGLL4-mediated transcriptional repression in Hippo pathway regulation and inform potential strategies to modulate Hippo signaling in cancer and regenerative medicine.